Review article · 2016
EditorialPublished 2014
Should be or Not Use Haematopoietic Growth Factors in the Case of Druginduced Agranulocytosis
Similar by topic
Case report · 12 Jul 2022
Primary Autoimmune Neutropenia in Infancy Presenting with Agranulocytosis: A Case Report
Conference abstract · 22 Nov 2024
Challenges in the management of antithyroid drug-induced agranulocytosis in a pregnant woman with Gravesâ?? disease - A Case Report
Conference abstract
Challenges in the management of antithyroid drug-induced agranulocytosis in a pregnant woman with Graves disease - A case report
Rapid communication · 25 Sep 2023
Explore new therapeutic approaches for the treatment of thrombocytopenia, including targeted drugs, immunomodulatory agents, and platelet growth factors
More from this journal
The newest in Journal of Blood Disorders & Transfusion.
Article · 8 Jun 2026
Analysis of Motivations and Barriers to Voluntary Blood Donation in the Thessalian Population: Findings from a Quantitative Study
Article · 30 Apr 2026
Cellular Neighbourhoods of Blood Formation: Understanding the Hematopoietic Microenvironment
Article · 30 Apr 2026
Erythrocyte Membrane Disorders: Structural Defects and Their Impact on Red Blood Cell Survival
Conferences in this field
Upcoming conferences in this field.
Follow
New articles from what you follow go into your email digest, once you agree to alert emails.
- JournalJournal of Blood Disorders & Transfusion
- SubjectHaematology
- BylineArticles whose byline prints “Emmanuel Andrès”
- BylineArticles whose byline prints “Rachel Mourot”
- BylineArticles whose byline prints “Olivier Keller”
- BylineArticles whose byline prints “Adrian Purcarea”
